Research Topic · Peer-Reviewed

Multidrug Resistance

Multidrug resistance (MDR) is the ability of microorganisms such as bacteria, fungi, viruses, and parasites to withstand the effects of several different drugs that would normally inhibit or kill them. It develops through genetic mutation and the acquisition or exchange of resistance genes, and it is driven and acce…

Curated from this journal's research 📚 10 peer-reviewed articles cited Cited 23× across the literature 🗓 Reviewed June 2026

Overview

Multidrug resistance (MDR) is the ability of microorganisms such as bacteria, fungi, viruses, and parasites to withstand the effects of several different drugs that would normally inhibit or kill them. It develops through genetic mutation and the acquisition or exchange of resistance genes, and it is driven and accelerated by the overuse and misuse of antimicrobials in medicine and agriculture. Multidrug resistance is a major global health concern because it renders standard treatments ineffective, leading to longer illnesses, higher mortality, greater healthcare costs, and the spread of resistant organisms within communities and hospitals. Combating it depends on surveillance, prudent antimicrobial use, infection prevention, and the development of new agents and diagnostics. Research published in Drug Resistant Pathogen Research and related journals documents these challenges, including the characterisation of rpoB gene mutations associated with rifampicin resistance in multidrug-resistant tuberculosis patients co-infected with HIV, the genotypic diversity of Salmonella Typhi isolates, the growing threat of carbapenem resistance among Klebsiella pneumoniae in a tertiary-care hospital, the detection of carbapenem-resistance mechanisms in avian pathogenic Escherichia coli, and a situational analysis of antimicrobial resistance in a health district in Cameroon. This page gathers peer-reviewed, open-access research relevant to antimicrobial resistance and resistant pathogens.

Research published in this journal

10 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 10 articles above have been cited 23 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Multidrug Resistance, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Drug Resistant Pathogen Research.

Journal editorial board
Maria Isabel Veiga · Portugal Eva Sapi · United States ZHUO WANG · United States

This page summarises published research for orientation; it is not medical or professional advice.